Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares were down 3.8% during mid-day trading on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The business’s 50-day moving average price is C$0.26 and its 200-day moving average price is C$0.26. The stock has a market cap of C$52.28 million and a PE ratio of -0.37. The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- Where to Find Earnings Call Transcripts
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is MarketRank™? How to Use it
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
